Sanjay Ahuja
Pediatric Hematology-Oncology Indianapolis, IN Medical Doctor
NPI 1306820717 CMS profile 240207
8326 Naab Rd, Indianapolis, IN 46260
General payments
$197,182
Research payments
$19,206
Ownership & investment interest
$0
Research they led as principal investigator
$1,213,842
Through program year 2025, Sanjay Ahuja of Indianapolis, IN is reported in the CMS Open Payments database as having received $197,182 across 308 general payments and $19,206 in research payments paid to them. Separately, studies naming them as principal investigator received $1,213,842 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Pediatric Hematology-Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
11 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $37,948 | 33 | |
| 2025 | Research | $8,442 | 4 | |
| 2024 | General | $65,967 | 63 | |
| 2024 | Research | $950 | 2 | |
| 2023 | General | $20,945 | 56 | |
| 2023 | Research | $9,166 | 5 | |
| 2022 | General | $26,466 | 51 | |
| 2021 | General | $7,745 | 18 | |
| 2020 | General | $11,386 | 21 | |
| 2019 | General | $26,725 | 66 | |
| 2019 | Research | $648 | 2 |
Beside peers
- Sanjay Ahuja
- Pediatric Hematology-Oncology median
- Middle half of Pediatric Hematology-Oncology
- National median
In program year 2025, general payments to Sanjay Ahuja were reported at $37,948. Among 1,352 Pediatric Hematology-Oncology profiles paid that year, the median was $204 and the middle half received between $80 and $2,819.
Show as a table
| Year | Sanjay Ahuja | Pediatric Hematology-Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $26,725 | $184 | $69–$2,094 | $163 |
| 2020 | $11,386 | $220 | $37–$3,941 | $114 |
| 2021 | $7,745 | $366 | $63–$4,909 | $132 |
| 2022 | $26,466 | $181 | $66–$2,775 | $149 |
| 2023 | $20,945 | $175 | $62–$2,600 | $160 |
| 2024 | $65,967 | $227 | $66–$2,992 | $164 |
| 2025 | $37,948 | $204 | $80–$2,819 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
321 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Hematology-Oncology in Indiana
Amy Shapiro
Pediatric Hematology-Oncology · Indianapolis, IN
Bassem Razzouk
Pediatric Hematology-Oncology · Indianapolis, IN
Melissa Bear
Pediatric Hematology-Oncology · Indianapolis, IN
Steven Rhodes
Pediatric Hematology-Oncology · Indianapolis, IN
Kyle Davis
Pediatric Hematology-Oncology · Indianapolis, IN
Seethal Jacob
Pediatric Hematology-Oncology · Indianapolis, IN
Related records
Pediatric Hematology-Oncology in Indiana
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Hematology-Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Indiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.